TABLE 2.
Comparison of interventions between psychiatrist-only and physician-pharmacist collaborative practice model (PPCPM) appointments
|
Appointment Type |
||
|
Psychiatrist Only |
PPCPM |
|
| BUP treatment | ||
| Average initial dose (mg/d) | 19.7 (±9.8) | 20.6 (±8.3) |
| Average end dose (mg/d) | 19.6 (±9.7) | 20.8 (±7.1) |
| Dosage range (mg/d) | 1-32 | 6-32 |
| Dose changes (%)a | 4 (11) | 4 (9) |
| Urine drug screening results | ||
| Samples collecteda | 32 (89) | 43 (98) |
| (–) BUPb | 5 (16) | 4 (9) |
| (+) Opioidb | 3 (9) | 3 (7) |
| (+) Illicit substance (noncannabinoid, nonopioid)b | 3 (9) | 3 (7) |
| Other MH medication interventions | ||
| Changes to MH medications (%)a | 11 (31) | 11 (25) |
| Naloxone prescriptions (%)a | 5 (14) | 8 (18) |
| Other supportive services | ||
| Service referrals (%)a | 10 (28) | 19 (43) |
| MOUD adherence issues addressed (%)c | 2 (8) | 15 (60) |
| Medication reconciliation interventions (%)a | 0 (0) | 21 (48) |
BUP = buprenorphine; MH = mental health.
a
Per total number of patient appointments.
b
Per total number of urine drug screens drawn.
c
Per total number of patients.